Beverages - Alcoholic
Compare Stocks
2 / 10Stock Comparison
BUD vs STZ
Revenue, margins, valuation, and 5-year total return — side by side.
Beverages - Wineries & Distilleries
BUD vs STZ — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Beverages - Alcoholic | Beverages - Wineries & Distilleries |
| Market Cap | $138.11B | $26.05B |
| Revenue (TTM) | $119.82B | $9.38B |
| Net Income (TTM) | $12.57B | $1.11B |
| Gross Margin | 55.2% | 52.0% |
| Operating Margin | 31.7% | 34.5% |
| Forward P/E | 18.8x | 12.7x |
| Total Debt | $72.17B | $12.11B |
| Cash & Equiv. | $11.17B | $68M |
BUD vs STZ — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Anheuser-Busch InBe… (BUD) | 100 | 171.2 | +71.2% |
| Constellation Brand… (STZ) | 100 | 87.0 | -13.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BUD vs STZ
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BUD is the clearest fit if your priority is momentum and efficiency.
- +24.5% vs STZ's -18.7%
- 6.0% ROA vs STZ's 5.1%, ROIC 7.5% vs 13.0%
STZ carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 4 yrs, beta 0.26, yield 2.7%
- Rev growth 2.5%, EPS growth -104.8%, 3Y rev CAGR 5.0%
- 12.6% 10Y total return vs BUD's -24.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 2.5% revenue growth vs BUD's 0.7% | |
| Value | Lower P/E (12.7x vs 18.8x) | |
| Quality / Margins | 11.8% margin vs BUD's 10.5% | |
| Stability / Safety | Beta 0.26 vs BUD's 0.28 | |
| Dividends | 2.7% yield, 4-year raise streak, vs BUD's 1.6% | |
| Momentum (1Y) | +24.5% vs STZ's -18.7% | |
| Efficiency (ROA) | 6.0% ROA vs STZ's 5.1%, ROIC 7.5% vs 13.0% |
BUD vs STZ — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BUD vs STZ — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BUD leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BUD is the larger business by revenue, generating $119.8B annually — 12.8x STZ's $9.4B. Profitability is closely matched — net margins range from 11.8% (STZ) to 10.5% (BUD). On growth, BUD holds the edge at +0.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $119.8B | $9.4B |
| EBITDAEarnings before interest/tax | $38.8B | $3.7B |
| Net IncomeAfter-tax profit | $12.6B | $1.1B |
| Free Cash FlowCash after capex | $32.2B | $1.8B |
| Gross MarginGross profit ÷ Revenue | +55.2% | +52.0% |
| Operating MarginEBIT ÷ Revenue | +31.7% | +34.5% |
| Net MarginNet income ÷ Revenue | +10.5% | +11.8% |
| FCF MarginFCF ÷ Revenue | +26.9% | +18.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +0.4% | -9.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +32.3% | -15.0% |
Valuation Metrics
Evenly matched — BUD and STZ each lead in 3 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, STZ's 9.4x EV/EBITDA is more attractive than BUD's 9.5x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $138.1B | $26.1B |
| Enterprise ValueMkt cap + debt − cash | $199.1B | $38.1B |
| Trailing P/EPrice ÷ TTM EPS | 28.06x | -333.89x |
| Forward P/EPrice ÷ next-FY EPS est. | 18.81x | 12.70x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 9.47x | 9.37x |
| Price / SalesMarket cap ÷ Revenue | 2.31x | 2.55x |
| Price / BookPrice ÷ Book value/share | 1.85x | 3.82x |
| Price / FCFMarket cap ÷ FCF | 12.34x | 13.44x |
Profitability & Efficiency
STZ leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
STZ delivers a 13.9% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $14 for BUD. BUD carries lower financial leverage with a 0.81x debt-to-equity ratio, signaling a more conservative balance sheet compared to STZ's 1.70x. On the Piotroski fundamental quality scale (0–9), BUD scores 9/9 vs STZ's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +13.8% | +13.9% |
| ROA (TTM)Return on assets | +6.0% | +5.1% |
| ROICReturn on invested capital | +7.5% | +13.0% |
| ROCEReturn on capital employed | +8.7% | +18.0% |
| Piotroski ScoreFundamental quality 0–9 | 9 | 5 |
| Debt / EquityFinancial leverage | 0.81x | 1.70x |
| Net DebtTotal debt minus cash | $61.0B | $12.0B |
| Cash & Equiv.Liquid assets | $11.2B | $68M |
| Total DebtShort + long-term debt | $72.2B | $12.1B |
| Interest CoverageEBIT ÷ Interest expense | 2.53x | 5.47x |
Total Returns (Dividends Reinvested)
BUD leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BUD five years ago would be worth $11,236 today (with dividends reinvested), compared to $6,992 for STZ. Over the past 12 months, BUD leads with a +24.5% total return vs STZ's -18.7%. The 3-year compound annual growth rate (CAGR) favors BUD at 8.4% vs STZ's -10.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +26.0% | +7.9% |
| 1-Year ReturnPast 12 months | +24.5% | -18.7% |
| 3-Year ReturnCumulative with dividends | +27.5% | -29.0% |
| 5-Year ReturnCumulative with dividends | +12.4% | -30.1% |
| 10-Year ReturnCumulative with dividends | -24.5% | +12.6% |
| CAGR (3Y)Annualised 3-year return | +8.4% | -10.8% |
Risk & Volatility
Evenly matched — BUD and STZ each lead in 1 of 2 comparable metrics.
Risk & Volatility
STZ is the less volatile stock with a 0.26 beta — it tends to amplify market swings less than BUD's 0.28 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BUD currently trades 96.8% from its 52-week high vs STZ's 76.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.28x | 0.26x |
| 52-Week HighHighest price in past year | $82.91 | $196.91 |
| 52-Week LowLowest price in past year | $56.97 | $126.45 |
| % of 52W HighCurrent price vs 52-week peak | +96.8% | +76.3% |
| RSI (14)Momentum oscillator 0–100 | 70.7 | 45.9 |
| Avg Volume (50D)Average daily shares traded | 2.0M | 1.8M |
Analyst Outlook
STZ leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates BUD as "Buy" and STZ as "Buy". Consensus price targets imply 16.9% upside for STZ (target: $176) vs 10.9% for BUD (target: $89). For income investors, STZ offers the higher dividend yield at 2.68% vs BUD's 1.63%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $89.00 | $175.70 |
| # AnalystsCovering analysts | 45 | 46 |
| Dividend YieldAnnual dividend ÷ price | +1.6% | +2.7% |
| Dividend StreakConsecutive years of raises | 0 | 4 |
| Dividend / ShareAnnual DPS | $1.31 | $4.03 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.7% | +4.3% |
BUD leads in 2 of 6 categories (Income & Cash Flow, Total Returns). STZ leads in 2 (Profitability & Efficiency, Analyst Outlook). 2 tied.
BUD vs STZ: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is BUD or STZ a better buy right now?
For growth investors, Constellation Brands, Inc.
(STZ) is the stronger pick with 2. 5% revenue growth year-over-year, versus 0. 7% for Anheuser-Busch InBev SA/NV (BUD). Anheuser-Busch InBev SA/NV (BUD) offers the better valuation at 28. 1x trailing P/E (18. 8x forward), making it the more compelling value choice. Analysts rate Anheuser-Busch InBev SA/NV (BUD) a "Buy" — based on 45 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BUD or STZ?
On forward P/E, Constellation Brands, Inc.
is actually cheaper at 12. 7x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — BUD or STZ?
Over the past 5 years, Anheuser-Busch InBev SA/NV (BUD) delivered a total return of +12.
4%, compared to -30. 1% for Constellation Brands, Inc. (STZ). Over 10 years, the gap is even starker: STZ returned +12. 6% versus BUD's -24. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BUD or STZ?
By beta (market sensitivity over 5 years), Constellation Brands, Inc.
(STZ) is the lower-risk stock at 0. 26β versus Anheuser-Busch InBev SA/NV's 0. 28β — meaning BUD is approximately 7% more volatile than STZ relative to the S&P 500. On balance sheet safety, Anheuser-Busch InBev SA/NV (BUD) carries a lower debt/equity ratio of 81% versus 170% for Constellation Brands, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BUD or STZ?
By revenue growth (latest reported year), Constellation Brands, Inc.
(STZ) is pulling ahead at 2. 5% versus 0. 7% for Anheuser-Busch InBev SA/NV (BUD). On earnings-per-share growth, the picture is similar: Anheuser-Busch InBev SA/NV grew EPS 10. 0% year-over-year, compared to -104. 8% for Constellation Brands, Inc.. Over a 3-year CAGR, STZ leads at 5. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BUD or STZ?
Anheuser-Busch InBev SA/NV (BUD) is the more profitable company, earning 9.
8% net margin versus -0. 8% for Constellation Brands, Inc. — meaning it keeps 9. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: STZ leads at 35. 5% versus 25. 9% for BUD. At the gross margin level — before operating expenses — BUD leads at 55. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BUD or STZ more undervalued right now?
On forward earnings alone, Constellation Brands, Inc.
(STZ) trades at 12. 7x forward P/E versus 18. 8x for Anheuser-Busch InBev SA/NV — 6. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for STZ: 16. 9% to $175. 70.
08Which pays a better dividend — BUD or STZ?
All stocks in this comparison pay dividends.
Constellation Brands, Inc. (STZ) offers the highest yield at 2. 7%, versus 1. 6% for Anheuser-Busch InBev SA/NV (BUD).
09Is BUD or STZ better for a retirement portfolio?
For long-horizon retirement investors, Constellation Brands, Inc.
(STZ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 26), 2. 7% yield). Both have compounded well over 10 years (STZ: +12. 6%, BUD: -24. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BUD and STZ?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.